13 research outputs found
The history of Irish in Co. Tipperary 1700-1901
Stair na Gaeilge i gCo. Thiobraid Ărann i rith na trĂ©imhse 1700-1901 atĂĄ ĂĄ rĂomhadh sa trĂĄchtas seo. Tar Ă©is a cĂșlra agus a comhthĂ©acs a shuĂomh i gCaibidil a hAon, dĂ©antar scrĂobhaithe an cheantair a ĂĄireamh, fara trĂĄchtaireacht orthu, i gCaibidil a DĂł. I gCaibidlĂ a TrĂ agus a Ceathair, fĂ©achtar ar thionchar na hEaglaisĂ CaitlicĂ agus Eaglais na hĂireann (i measc eaglaisĂ ProtastĂșnacha eile) ar an dteangain. I gCaibidil a CĂșig, faightear splĂ©achadh ar ghnĂ©ithe Ă©agsĂșla de shaĂocht an chontae, ag tabhairt lĂ©argais ar thĂĄirgĂ na scrĂobhaithe, ar leabhair a clĂłbhualadh sa rĂ©igiĂșn, agus ar fhilĂ mĂłra na hĂĄite, leithĂ©idĂ Liam Daill UĂ IfearnĂĄin, ag sonrĂș limistĂ©ir faoi leith, an t-oirdheisceart, mar shampla. LĂ©irĂtear Ă©ifeacht na gcumann Gaelach agus na ndĂograiseoirĂ iomadĂșla a bhain leo. Ăbhar suime, leis, feidhm na Gaeilge sna cĂșirteanna dlĂ. Tugtar faisnĂ©is i gCaibidil a SĂ© ar fhianaise cuairteoirĂ ar an Ghaeilge mar urlabhra i dTiobraid Ărann. Is anseo chomh maith a deintear anailĂs ar DhaonĂĄirimh na mblianta 1861-1901, le mĂłrchuid adhmaid ĂĄ baint as ceann 1901 go hĂĄirithe. Breactar as ainmneacha sagart agus mĂșinteoirĂ le Gaeilge, agus trĂĄchtar ar aicmĂ suntasacha eile, na pĂłilĂnĂ agus na saighdiĂșirĂ a raibh an teanga sin ina mbĂ©al acu. Tugtar le chĂ©ile dĂĄ rĂ©ir na snĂĄithĂnĂ difriĂșla eolais ar an dĂșiche ar bhealach nĂĄr tharla cheana don gcontae casta fairsing seo le haghaidh na trĂ©imhse atĂĄ idir lĂĄmha ag an saothar.This thesis traces the fortunes of the Irish language in Co. Tipperary during the period 1700-1901. After sketching the background and context in Chapter One, the regionâs scribes are identified and discussed in Chapter Two. The third and fourth chapters deal, respectively, with the influence of the Roman Catholic Church and of the Church of Ireland (among other Protestant denominations) on the areaâs language. Different aspects of the countyâs cultural traditions are explored in Chapter Five, particulary its scribal output, as well as Irish-language books published in Tipperary, together with its notable poets, such as Liam Dall Ă hIfearnĂĄin, with a specific focus on the south-east as a case study. The impact of language organisations and of the many enthusiasts associated with them is assessed. Attention is also paid to the workings of Irish in the law courts. Evidence reported by visitors to Co. Tipperary on Irish as a spoken language there is presented in Chapter Six. Here also data from censuses of the period 1861-1901 are investigated, with a particular focus on the 1901 Census. Among strands extracted from the latter are the names of priests and teachers conversant with Irish, together with discussion of other significant occupational classes, such as police and soldiers who knew the language. Different strands of the story of Irish in the study region are thus brought together for the time horizon at issue in a way which has not occurred previously for this diverse and extensive count
Expression of Heterologous Antigens in Commensal Neisseria spp.: Preservation of Conformational Epitopes with Vaccine Potential
Commensal neisseriae share with Neisseria meningitidis (meningococcus) a tendency towards overproduction of the bacterial outer envelope, leading to the formation and release during growth of outer membrane vesicles (OMVs). OMVs from both meningococci and commensal neisseriae have shown promise as vaccines to protect against meningococcal disease. We report here the successful expression at high levels of heterologous proteins in commensal neisseriae and the display, in its native conformation, of one meningococcal outer membrane protein vaccine candidate, NspA, in OMVs prepared from such a recombinant Neisseria flavescens strain. These NspA-containing OMVs conferred protection against otherwise lethal intraperitoneal challenge of mice with N. meningitidis serogroup B, and sera raised against them mediated opsonophagocytosis of meningococcal strains expressing this antigen. This development promises to facilitate the design of novel vaccines containing membrane protein antigens that are otherwise difficult to present in native conformation that provide cross-protective efficacy in the prevention of meningococcal disease
A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia
This retrospective analysis assessed the response, safety and duration of response to standard dose rituximab 375 mg/m(2) weekly for four weeks as therapy for patients with primary or secondary warm autoimmune haemolytic anaemia (WAIHA), who had failed initial treatment. Thirty-four patients received rituximab for WAIHA in seven centres in the Republic of Ireland. The overall response rate was 70 center dot 6% (24/34) with 26 center dot 5% (9/34) achieving a complete response (CR). The time to response was 1 month post-initiation of rituximab in 87 center dot 5% (21/24) and 3 months in 12 center dot 5% (3/24) of patients. The median duration of follow-up was 36 months (range 6-90 months). Of the patients who responded, 50% (12/24) relapsed during follow up with a median time to next treatment of 16 center dot 5 months (range 6-60 months). Three patients were re-treated with rituximab 375 mg/m2 weekly for four weeks at relapse and responded. There was a single episode of neutropenic sepsis. Rituximab is an effective and safe treatment for WAIHA but a significant number of patients will relapse in the first two years post treatment. Re-treatment was effective in a small number of patients, suggesting that intermittent pulse treatment or maintenance treatment may improve long-term response
Bioengineering approaches to study multidrug resistance in tumor cells
The ability of cancer cells to become resistant to chemotherapeutic agents is a major challenge for the treatment of malignant tumors. Several strategies have emerged to attempt to inhibit chemoresistance, but the fact remains that resistance is a problem for every effective anticancer drug. The first part of this review will focus on the mechanisms of chemoresistance. It is important to understand the environmental cues, transport limitations and the cellular signaling pathways associated with chemoresistance before we can hope to effectively combat it. The second part of this review focuses on the work that needs to be done moving forward. Specifically, this section focuses on the necessity of translational research and interdisciplinary directives. It is critical that the expertise of oncologists, biologists, and engineers be brought together to attempt to tackle the problem. This discussion is from an engineering perspective, as the dialogue between engineers and other cancer researchers is the most challenging due to non-overlapping background knowledge. Chemoresistance is a complex and devastating process, meaning that we urgently need sophisticated methods to study the process of how cells become resistant